Drug Safety

, Volume 24, Issue 4, pp 277–322 | Cite as

Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy

Review Article

Abstract

Cigarette smoking during pregnancy is the single largest modifiable risk for pregnancy-related morbidity and mortality in the US. Addiction to nicotine prevents many pregnant women who wish to quit smoking from doing so. The safety and efficacy of nicotine replacement therapy (NRT) for smoking cessation during pregnancy have not been well studied.

Nicotine is classified by the US Food and Drug Administration as a Pregnancy Category D drug. Animal studies indicate that nicotine adversely affects the developing fetal CNS, and nicotine effects on the brain may be involved in the pathophysiology of sudden infant death syndrome (SIDS). It has been assumed that the cardiovascular effects of nicotine resulting in reduced blood flow to the placenta (uteroplacental insufficiency) is the predominant mechanism of the reproductive toxicity of cigarette smoking during pregnancy. Short term high doses of nicotine in pregnant animals do adversely affect the maternal and fetal cardiovascular systems. However, studies of the acute effects of NRT in pregnant humans indicate that nicotine alone has minimal effects upon the maternal and fetal cardiovascular systems.

Cigarette smoking delivers thousands of chemicals, some of which are well documented reproductive toxins (e.g. carbon monoxide and lead). A myriad of cellular and molecular biological abnormalities have been documented in placentas, fetuses, and newborns of pregnant women who smoke. The cumulative abnormalities produced by the various toxins in cigarette smoke are probably responsible for the numerous adverse reproductive outcomes associated with smoking. It is doubtful that the reproductive toxicity of cigarette smoking is primarily related to nicotine.

We recommend the following. Efficacy trials of NRT as adjunctive therapy for smoking cessation during pregnancy should be conducted. The initial dose of nicotine in NRT should be similar to the dose of nicotine that the pregnant woman received from smoking. Intermittent-use formulations of NRT (gum, spray, inhaler) are preferred because the total dose of nicotine delivered to the fetus will be less than with continuous-use formulations (transdermal patch). A national registry for NRT use during pregnancy should be created to prospectively collect obstetrical outcome data from NRT efficacy trials and from individual use. The goal of this registry would be to determine the safety of NRT use during pregnancy, especially with respect to uncommon outcomes such as placental abruption. Finally, our review of the data indicate that minimal amounts of nicotine are excreted into breast milk and that NRT can be safely used by breast-feeding mothers.

References

  1. 1.
    Adams EK, Solanki G, Miller LS. Medical-care expenditures attributable to cigarette smoking during pregnancy - United States, 1995. MMWR Morbid Mort Wkly Rep 1997; 46: 1048–50Google Scholar
  2. 2.
    Hoffmann D, Djordjevic MV, Hoffman I. The changing cigarette. Prev Med 1997; 26: 427–34PubMedCrossRefGoogle Scholar
  3. 3.
    Benowitz NL. Pharmacology of nicotine: Addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996; 36: 597–613PubMedCrossRefGoogle Scholar
  4. 4.
    Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 1998; 285: 931–45PubMedGoogle Scholar
  5. 5.
    Benowitz NL, Porchet H, Jacob III P. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP, editors. Nicotine psychopharmacology: molecular, cellular and behavioral aspects. Oxford: Oxford University Press, 1990: 112–57Google Scholar
  6. 6.
    Dempsey DA, Jacob III P, Benowitz NL. Accelerated N-glucuronidation of nicotine and cotinine during pregnancy [abstract]. Clin Pharmacol Ther 1999; 65: 200CrossRefGoogle Scholar
  7. 7.
    Dempsey DA, Jacob III P, Benowitz NL. Accelerated nicotine and cotinine metabolism during pregnancy [abstract]. Clin Pharmacol Ther 1998; 63: 202Google Scholar
  8. 8.
    Ogburn Jr PL, Hurt RD, Croghan IT, et al. Nicotine patch use in pregnant smokers: Nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999; 181: 736–43PubMedCrossRefGoogle Scholar
  9. 9.
    Rebagliato M, Bolumar F, Florey CdV, et al. Variations in cotinine levels in smokers during and after pregnancy. Am J Obstet Gynecol 1998; 178: 568–71PubMedCrossRefGoogle Scholar
  10. 10.
    Oncken CA, Hardardottir H, Hatsukami DK, et al. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol 1997; 90: 569–74PubMedCrossRefGoogle Scholar
  11. 11.
    Wright LN, Thorp Jr JM, Kuller JA, et al. Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol 1997; 176: 1090–4PubMedCrossRefGoogle Scholar
  12. 12.
    Rose JE, Levin ED, Benowitz N. Saliva nicotine as an index of plasma levels in nicotine skin patch users. Ther Drug Monit 1993; 15: 431–5PubMedCrossRefGoogle Scholar
  13. 13.
    Gennser G, Marsal K, Brantmark B. Maternal smoking and fetal breathing movements. Am J Obstet Gynecol 1975; 123: 861–7PubMedGoogle Scholar
  14. 14.
    Manning FA, Feyerabend C. Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol 1976; 83: 262–70PubMedCrossRefGoogle Scholar
  15. 15.
    Lindblad A, Marsal K, Andersson KE. Effect of nicotine on human fetal blood flow. Obstet Gynecol 1988; 72: 371–82PubMedGoogle Scholar
  16. 16.
    Oncken CA, Hatsukami DK, Lupo VR, et al. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 1996; 59: 654–61PubMedCrossRefGoogle Scholar
  17. 17.
    Suzuki K, Horiguchi T, Comas-Urrutia AC, et al. Placental transfer and distribution of nicotine in the pregnant rhesus monkey. Am J Obstet Gynecol 1974; 119: 253–62PubMedGoogle Scholar
  18. 18.
    Luck W, Nau H. Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smoking [letter]. N Engl J Med 1984; 311: 672PubMedCrossRefGoogle Scholar
  19. 19.
    Luck W, Nau H. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers. J Pediatr 1985; 107: 816–20PubMedCrossRefGoogle Scholar
  20. 20.
    Donnenfeld AE, Pulkkinen A, Palomaki GE, etal. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993; 168: 781–2PubMedGoogle Scholar
  21. 21.
    Sastry BV, Chance MB, Hemontolor ME, et al. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 1998; 57: 104–16PubMedCrossRefGoogle Scholar
  22. 22.
    Cunningham FG, MacDonald PC, Gant NF, et al. Fetal growth restriction. In: Cunningham FG, editor. Williams obstetrics. 20th ed. Stamford, (CT): Appleton & Lange, 1997: 839–54Google Scholar
  23. 23.
    Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996; 20: 115–26PubMedCrossRefGoogle Scholar
  24. 24.
    Craigo SD. The role of ultrasound in the diagnosis and management of intrauterine growth retardation. Sem Perinatal 1994; 18: 292–304Google Scholar
  25. 25.
    Craigo SD, Beach ML, Harvey-Wilkes KB, et al. Ultrasound predictors of neonatal outcome in intrauterine growth restriction. Am J Perinat 1996; 13: 465–71CrossRefGoogle Scholar
  26. 26.
    Phelan JP. Diminished fetal reactivity with smoking. Am J Obstet Gynecol 1980; 136: 230–3PubMedGoogle Scholar
  27. 27.
    Newnham JP, Patterson L, James I, et al. Effects of maternal cigarette smoking on ultrasonic measurements of fetal growth and on Doppler flow velocity waveforms. Early Hum Dev 1990; 24: 23–36PubMedCrossRefGoogle Scholar
  28. 28.
    Eldridge MW, Berman Jr W, Greene ER. Chronic maternal cigarette smoking and fetal abdominal aortic blood flow in humans. J Ultrasound Med 1986; 5: 131–6PubMedGoogle Scholar
  29. 29.
    Sindberg Eriksen P, Marsal K. Circulatory changes in the fetal aorta after maternal smoking. Br J Obstet Gynaecol 1987; 94: 301–5PubMedCrossRefGoogle Scholar
  30. 30.
    Sindberg Eriksen P, Gennser G, Lindvall R, et al. Acute effects of maternal smoking on fetal heart beat intervals. Acta Obstet Gynecol Scand 1984; 63: 385–90PubMedCrossRefGoogle Scholar
  31. 31.
    Eriksen PS, Gennser G, Lofgren O, et al. Acute effects of maternal smoking on fetal breathing and movements. Obstet Gynecol 1983; 61: 367–72PubMedGoogle Scholar
  32. 32.
    Sindberg Eriksen P, Gennser G. Acute responses to maternal smoking of the pulsatile movements in fetal aorta. Acta Obstet Gynecol Scand 1984; 63: 647–54PubMedCrossRefGoogle Scholar
  33. 33.
    Jouppila P, Kirkinen P, Eik-Nes S. Acute effect of maternal smoking on the human fetal blood flow. Br J Obstet Gynaecol 1983; 90: 7–10PubMedCrossRefGoogle Scholar
  34. 34.
    Lindblad A, Marsal K. Influence of nicotine chewing gum on fetal blood flow. J Perinat Med 1987; 15: 13–9PubMedCrossRefGoogle Scholar
  35. 35.
    Forss M, Lehtovirta P, Rauramo I, et al. Midtrimester fetal heart rate variability and maternal hemodynamics in association with smoking. Am J Obstet Gynecol 1983; 146: 693–5PubMedGoogle Scholar
  36. 36.
    Kariniemi V, Forss M, Lehtovirta P, et al. Significant correlation between maternal hemodynamics and fetal heart rate variability. Am J Obstet Gynecol 1982; 144: 43–6PubMedGoogle Scholar
  37. 37.
    Kariniemi V, Lehtovirta P, Rauramo I, et al. Effects of smoking on fetal heart rate variability during gestational weeks 27 to 32. Am J Obstet Gynecol 1984; 149: 575–6PubMedGoogle Scholar
  38. 38.
    Lehtovirta P, Forss M, Kariniemi V, et al. Acute effects of smoking on fetal heart-rate variability. Br J Obstet Gynaecol 1983; 90: 3–6PubMedCrossRefGoogle Scholar
  39. 39.
    Lehtovirta P, Forss M. The acute effect of smoking on intervillous blood flow of the placenta. Br J Obstet Gynaecol 1978; 85: 729–31PubMedCrossRefGoogle Scholar
  40. 40.
    Lehtovirta P, Forss M. The acute effect ofsmoking on uteroplacental blood flow in normotensive and hypertensive pregnancy. Int J Gynaecol Obstet 1980; 18: 208–11PubMedGoogle Scholar
  41. 41.
    Rauramo I, Forss M, Kariniemi V, et al. Antepartum fetal heart rate variability and intervillous placental blood flow in association with smoking. Am J Obstet Gynecol 1983; 146: 967–9PubMedGoogle Scholar
  42. 42.
    Bruner JP, Forouzan I. Smoking and buccally administered nicotine. Acute effect on uterine and umbilical artery Doppler flow velocity waveforms. J Reprod Med 1991; 36: 435–40PubMedGoogle Scholar
  43. 43.
    Castro LC, Allen R, Ogunyemi D, et al. Cigarette smoking during pregnancy: acute effects on uterine flow velocity waveforms. Obstet Gynecol 1993; 81: 551–5PubMedGoogle Scholar
  44. 44.
    Barrett JM, Vanhooydonk JE, Boehm FH. Acute effect of cigarette smoking on the fetal heart nonstress test. Obstet Gynecol 1981; 57: 422–5PubMedGoogle Scholar
  45. 45.
    Nylund L, Lunell NO, Persson B, et al. Acute metabolic and circulatory effects of cigarette smoking in late pregnancy. Gynecol Obstet Invest 1979; 10: 39–45PubMedCrossRefGoogle Scholar
  46. 46.
    Philipp K, Pateisky N, Endler M. Effects of smoking on uteroplacental blood flow. Gynecol Obstet Invest 1984; 17: 179–82PubMedCrossRefGoogle Scholar
  47. 47.
    Quigley ME, Sheehan KL, Wilkes MM, et al. Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol 1979; 133: 685–90PubMedGoogle Scholar
  48. 48.
    Agudelo R, Schneider KT, Dumler EA, et al. The effect of smoking on the resistance index of the umbilical artery and the middle cerebral artery. Geburtshilfe Frauenheilkd 1992; 52: 549–52PubMedCrossRefGoogle Scholar
  49. 49.
    Graca LM, Cardoso CG, Clode N, et al. Acute effects of maternal cigarette smoking on fetal heart rate and fetal body movements felt by the mother. J Perinat Med 1991; 19: 385–90PubMedCrossRefGoogle Scholar
  50. 50.
    Thaler I, Goodman JD, Dawes GS. Effects of maternal cigarette smoking on fetal breathing and fetal movements. Am J Obstet Gynecol 1980; 138: 282–7PubMedGoogle Scholar
  51. 51.
    Goodman JD, Visser FG, Dawes GS. Effects of maternal cigarette smoking on fetal trunk movements, fetal breathing movements and the fetal heart rate. Br J Obstet Gynaecol 1984; 91: 657–61PubMedCrossRefGoogle Scholar
  52. 52.
    Huisman M, Risseeuw B, van Eyck J, et al. Nicotine and caffeine. Influence on prenatal hemodynamics and behavior in early twin pregnancy. J Reprod Med 1997; 42: 731–4PubMedGoogle Scholar
  53. 53.
    Morrow RJ, Ritchie JW, Bull SB. Maternal cigarette smoking: the effects on umbilical and uterine blood flow velocity. Am J Obstet Gynecol 1988; 159: 1069–71PubMedGoogle Scholar
  54. 54.
    Sorensen KE, Borlum KG. Acute effects of maternal smoking on human fetal heart function. Acta Obstet Gynecol Scand 1987; 66: 217–20PubMedCrossRefGoogle Scholar
  55. 55.
    Pijpers L, Wladimiroff JW, McGhie JS, et al. Acute effect of maternal smoking on the maternal and fetal cardiovascular system. Early Hum Dev 1984; 10: 95–105PubMedCrossRefGoogle Scholar
  56. 56.
    Manning F, Wyn Pugh E, Boddy K. Effect of cigarette smoking on fetal breathing movements in normal pregnancies. BMJ 1975; 1: 552–3PubMedCrossRefGoogle Scholar
  57. 57.
    Socol ML, Manning FA, Murata Y, et al. Maternal smoking causes fetal hypoxia: experimental evidence. Am J Obstet Gynecol 1982; 142: 214–8PubMedGoogle Scholar
  58. 58.
    Suzuki K, Horiguchi T, Comas-Urrutia AC, et al. Pharmacologic effects of nicotine upon the fetus and mother in the rhesus monkey. Am J Obstet Gynecol 1971; 111: 1092–101PubMedGoogle Scholar
  59. 59.
    Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 1980; 136: 1009–13PubMedGoogle Scholar
  60. 60.
    McTiernan MJ, Burchfield DJ, Abrams RM, et al. Carboxy- and oxyhemoglobin in pregnant ewe and fetus after inhalation of marijuana, marijuana placebo and tobacco cigarette smoke. Life Sci 1988; 43: 2043–7PubMedCrossRefGoogle Scholar
  61. 61.
    Kirschbaum TH, Dilts Jr PV, Brinkman CRD. Some acute effects of smoking in sheep and their fetuses. Obstet Gynecol 1970; 35: 527–36PubMedGoogle Scholar
  62. 62.
    Manning F, Walker D, Feyerabend C. The effect ofnicotine on fetal breathing movements in conscious pregnant ewes. Obstet Gynecol 1978; 52: 563–8PubMedGoogle Scholar
  63. 63.
    Resnik R, Brink GW, Wilkes M. Catecholamine-mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe. J Clin Invest 1979; 63: 1133–6PubMedCrossRefGoogle Scholar
  64. 64.
    Ayromlooi J, Desiderio D, Tobias M. Effect of nicotine sulfate on the hemodynamics and acid base balance of chronically instrumented pregnant sheep. Dev Pharmacol Ther 1981; 3: 205–13PubMedGoogle Scholar
  65. 65.
    Monheit AG, VanVunakis H, Key TC, et al. Maternal and fetal cardiovascular effects of nicotine infusion in pregnant sheep. Am J Obstet Gynecol 1983; 145: 290–6PubMedGoogle Scholar
  66. 66.
    Resnik R, Conover WB, Key TC, et al. Uterine blood flow and catecholamine response to repetitive nicotine exposure in the pregnant ewe. Am J Obstet Gynecol 1985; 151: 885–91PubMedGoogle Scholar
  67. 67.
    Clark KE, Irion GL. Fetal hemodynamic response to maternal intravenous nicotine administration. Am J Obstet Gynecol 1992; 167: 1624–31PubMedGoogle Scholar
  68. 68.
    Arbeille P, Bosc M, Vaillant MC, et al. Nicotine-induced changes in the cerebral circulation in ovine fetuses. Am J Perinatol 1992; 9: 270–4PubMedCrossRefGoogle Scholar
  69. 69.
    Kaufmann RC, Amankwah KS, Weberg AD. The effect of maternal smoke exposure on the ultrastructure of fetal peripheral blood vessels in the mouse. J Perinat Med 1986; 14: 309–17PubMedCrossRefGoogle Scholar
  70. 70.
    Tomasi AM, Lee H, Myers S. The hemodynamic response of the conscious pregnant guinea pig to nicotine. Am J Obstet Gynecol 1987; 156: 1015–8PubMedGoogle Scholar
  71. 71.
    Hammer RE, Goldman H, Mitchell JA. Effects of nicotine on uterine blood flow and intrauterine oxygen tension in the rat. J Reprod Fertil 1981; 63: 163–8PubMedCrossRefGoogle Scholar
  72. 72.
    Birnbaum SC, Kien N, Martucci RW, et al. Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat. Toxicology 1994; 94: 69–80PubMedCrossRefGoogle Scholar
  73. 73.
    Nash JE, Persaud TV. Influence of nicotine and caffeine on rat embryonic development. Histol Histopathol 1988; 3: 377–88PubMedGoogle Scholar
  74. 74.
    Sheina NI. Quantitative study of the morphofunctional changes in the placenta of rats exposed to nicotine at various periods of pregnancy. Farmakol Toksikol 1983; 46: 93–6PubMedGoogle Scholar
  75. 75.
    Bassi JA, Rosso P, Moessinger AC, et al. Fetal growth retardation due to maternal tobacco smoke exposure in the rat. Pediatr Res 1984; 18: 127–30PubMedCrossRefGoogle Scholar
  76. 76.
    Leichter J. Growth of fetuses of rats exposed to ethanol and cigarette smoke during gestation. Growth Dev Aging 1989; 53: 129–34PubMedGoogle Scholar
  77. 77.
    Leichter J. Decreased birth weight and attainment of postnatal catch-up growth in offspring of rats exposed to cigarette smoke during gestation. Growth Dev Aging 1995; 59: 63–6PubMedGoogle Scholar
  78. 78.
    Martin JC, Martin DC, Radow B, et al. Growth, development and activity in rat offspring following maternal drug exposure. Exp Aging Res 1976; 2: 235–51PubMedCrossRefGoogle Scholar
  79. 79.
    Mitchell JA, Hammer RE. Effects of nicotine on oviducal blood flow and embryo development in the rat. J Reprod Fertil 1985; 74: 71–6PubMedCrossRefGoogle Scholar
  80. 80.
    Hamosh M, Simon MR, Hamosh P. Effect of nicotine on the development of fetal and suckling rats. Biol Neonate 1979; 35: 290–7PubMedCrossRefGoogle Scholar
  81. 81.
    Witschi H, Lundgaard SM, Rajini P, et al. Effects of exposure to nicotine and to sidestream smoke on pregnancy outcome in rats. Toxicol Lett 1994; 71: 279–86PubMedCrossRefGoogle Scholar
  82. 82.
    Baer DS, McClearn GE, Wilson JR. Fertility, maternal care, and offspring behavior in mice prenatally treated with tobacco smoke. Dev Psychobiol 1980; 13: 643–52PubMedCrossRefGoogle Scholar
  83. 83.
    Bertolini A, Bernardi M, Genedani S. Effects of prenatal exposure to cigarette smoke and nicotine on pregnancy, offspring development and avoidance behavior in rats. Neurobehav Toxicol Teratol 1982; 4: 545–8PubMedGoogle Scholar
  84. 84.
    Peters DA, Taub H, Tang S. Postnatal effects of maternal nicotine exposure. Neurobehav Toxicol 1979; 1: 221–5PubMedGoogle Scholar
  85. 85.
    Peters DA, Tang S. Sex-dependent biological changes following prenatal nicotine exposure in the rat. Pharmacol Biochem Behav 1982; 17: 1077–82PubMedCrossRefGoogle Scholar
  86. 86.
    Sorenson CA, Raskin LA, Suh Y. The effects of prenatal nicotine on radial-arm maze performance in rats. Pharmacol Biochem Behav 1991; 40: 991–3PubMedCrossRefGoogle Scholar
  87. 87.
    Paulson RB, Shanfeld J, Vorhees CV, et al. Behavioral effects of prenatally administered smokeless tobacco on rat offspring. Neurotoxicol Teratol 1993; 15: 183–92PubMedCrossRefGoogle Scholar
  88. 88.
    Paulson RB, Shanfeld J, Vorhees CV, et al. Behavioral effects of smokeless tobacco on the neonate and young Sprague Dawley rat. Teratology 1994; 49: 293–305PubMedCrossRefGoogle Scholar
  89. 89.
    Martin JC, Martin DC. Voluntary activity in the aging rat as a function of maternal drug exposure. Neurobehav Toxicol Teratol 1981; 3: 261–4PubMedGoogle Scholar
  90. 90.
    Peters MA, Ngan LL. The effects of totigestational exposure to nicotine on pre- and postnatal development in the rat. Arch Int Pharmacodyn Ther 1982; 257: 155–67PubMedGoogle Scholar
  91. 91.
    Martin JC, Martin DC, Chao S, et al. Interactive effects of chronic maternal ethanol and nicotine exposure upon offspring development and function. Neurobehav Toxicol Teratol 1982; 4: 293–8PubMedGoogle Scholar
  92. 92.
    Johns JM, Louis TM, Becker RF, et al. Behavioral effects of prenatal exposure to nicotine in guinea pigs. Neurobehav Toxicol Teratol 1982; 4: 365–9PubMedGoogle Scholar
  93. 93.
    Genedani S, Bernardi M, Bertolini A. Sex-linked differences in avoidance learning in the offspring of rats treated with nicotine during pregnancy. Psychopharmacology (Berl) 1983; 80: 93–5CrossRefGoogle Scholar
  94. 94.
    Al-Hachim GM, Mahmoud FA. Prenatal nicotine and CNS development. Epilepsia 1985; 26: 661–5PubMedCrossRefGoogle Scholar
  95. 95.
    King JA, Strand FL. Is nicotine depression of neonatal motor behavior exerted through ACTH release? Peptides 1988; 9Suppl. 1: 39–44PubMedCrossRefGoogle Scholar
  96. 96.
    Johns JM, Walters PA, Zimmerman LI. The effects of chronic prenatal exposure to nicotine on the behavior of guinea pigs (Cavia porcellus). J Gen Psychol 1993; 120: 49–63PubMedCrossRefGoogle Scholar
  97. 97.
    Ajarem JS, Ahmad M. Prenatal nicotine exposure modifies behavior of mice through early development. Pharmacol Biochem Behav 1998; 59: 313–8PubMedCrossRefGoogle Scholar
  98. 98.
    Schlumpf M, Gahwiler M, Ribary U, et al. A new device for monitoring early motor development: prenatal nicotine-induced changes. Pharmacol Biochem Behav 1988; 30: 199–203PubMedCrossRefGoogle Scholar
  99. 99.
    Cutler AR, Wilkerson AE, Gingras JL, et al. Prenatal cocaine and/or nicotine exposure in rats: preliminary findings on long-term cognitive outcome and genital development at birth. Neurotoxicol Teratol 1996; 18: 635–43PubMedCrossRefGoogle Scholar
  100. 100.
    Levin ED, Wilkerson A, Jones JP, et al. Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges. Brain Res Dev Brain Res 1996; 97: 207–15PubMedCrossRefGoogle Scholar
  101. 101.
    Shacka JJ, Fennell OB, Robinson SE. Prenatal nicotine sexdependently alters agonist-induced locomotion and stereotypy. Neurotoxicol Teratol 1997; 19: 467–76PubMedCrossRefGoogle Scholar
  102. 102.
    Popke EJ, Tizabi Y, Rahman MA, et al. Prenatal exposure to nicotine: effects on prepulse inhibition and central nicotinic receptors. Pharmacol Biochem Behav 1997; 58: 843–9PubMedCrossRefGoogle Scholar
  103. 103.
    Fung YK. Postnatal behavioural effects of maternal nicotine exposure in rats. J Pharm Pharmacol 1988; 40: 870–2PubMedCrossRefGoogle Scholar
  104. 104.
    Segarra AC, Strand FL. Perinatal administration of nicotine alters subsequent sexual behavior and testosterone levels of male rats. Brain Res 1989; 480: 151–9PubMedCrossRefGoogle Scholar
  105. 105.
    Rose KJ, Strand FL. A sensitive period in gestation for nicotine acceleration of neuromuscular maturation. Int J Dev Neurosci 1991; 9: 297–305PubMedCrossRefGoogle Scholar
  106. 106.
    Levin ED, Briggs SJ, Christopher NC, et al. Prenatal nicotine exposure and cognitive performance in rats. Neurotoxicol Teratol 1993; 15: 251–60PubMedCrossRefGoogle Scholar
  107. 107.
    Nordberg A, Zhang XA, Fredriksson A, et al. Neonatal nicotine exposure induces permanent changes in brain nicotinic receptors and behaviour in adult mice. Brain Res Dev Brain Res 1991; 63: 201–7PubMedCrossRefGoogle Scholar
  108. 108.
    Britos SA, Orsingher OA. Prenatal nicotine exposure increased susceptibility to electroconvulsive shock (ECS) in adult rats. Neurotoxicol Teratol 1991; 13: 271–3PubMedCrossRefGoogle Scholar
  109. 109.
    Yanai J, Pick CG, Rogel-Fuchs Y, et al. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine. Brain Res Bull 1992; 29: 363–8PubMedCrossRefGoogle Scholar
  110. 110.
    Tizabi Y, Popke EJ, Rahman MA, et al. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors. Pharmacol Biochem Behav 1997; 58: 141–6PubMedCrossRefGoogle Scholar
  111. 111.
    Ehlers CL, Somes C, Thomas J, et al. Effects of neonatal exposure to nicotine on electrophysiological parameters in adult rats. Pharmacol Biochem Behav 1997; 58: 713–20PubMedCrossRefGoogle Scholar
  112. 112.
    Gospe Jr SM, Zhou SS, Pinkerton KE. Effects of environmental tobacco smoke exposure in utero and/or postnatally on brain development. Pediatr Res 1996; 39: 494–8PubMedCrossRefGoogle Scholar
  113. 113.
    Krous HF, Campbell GA, Fowler MW, et al. Maternal nicotine administration and fetal brain stem damage: a rat model with implications for sudden infant death syndrome. Am J Obstet Gynecol 1981; 140: 743–6PubMedGoogle Scholar
  114. 114.
    Peters DA. Prenatal nicotine exposure increases adrenergic receptor binding in the rat cerebral cortex. Res Commun Chem Pathol Pharmacol 1984; 46: 307–17PubMedGoogle Scholar
  115. 115.
    Zhu J, Taniguchi T, Konishi Y, et al. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates. Life Sci 1998; 62: 1089–98PubMedCrossRefGoogle Scholar
  116. 116.
    Slotkin TA, Greer N, Faust J, et al. Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. Brain Res Bull 1986; 17: 41–50PubMedCrossRefGoogle Scholar
  117. 117.
    Slotkin TA, Cho H, Whitmore WL. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res Bull 1987; 18: 601–11PubMedCrossRefGoogle Scholar
  118. 118.
    Smith WT, Seidler FJ, Slotkin TA. Acute stimulation of ornithine decarboxylase in neonatal rat brain regions by nicotine: a central receptor-mediated process? Brain Res Dev Brain Res 1991; 63: 85–93PubMedCrossRefGoogle Scholar
  119. 119.
    McFarland BJ, Seidler FJ, Slotkin TA. Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res 1991; 58: 223–9PubMedCrossRefGoogle Scholar
  120. 120.
    Barrios V, Rodriguez-Sanchez MN, Arilla E. Effect of maternal exposure to nicotine in the rat on level and binding of somatostatin in brain of developing offspring. Neuropharmacology 1991; 30: 579–84PubMedCrossRefGoogle Scholar
  121. 121.
    Roy TS, Sabherwal U. Effects of prenatal nicotine exposure on the morphogenesis of somatosensory cortex. Neurotoxicol Teratol 1994; 16: 411–21PubMedCrossRefGoogle Scholar
  122. 122.
    Seidler FJ, Albright ES, Lappi SE, et al. In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine: catecholamine release by nicotine in immature rat brain regions. Brain Res Dev Brain Res 1994; 82: 1–8PubMedCrossRefGoogle Scholar
  123. 123.
    Clegg DA, O’Hara BF, Heller HC, et al. Nicotine administration differentially affects gene expression in the maternal and fetal circadian clock. Brain Res Dev Brain Res 1995; 84: 46–54PubMedCrossRefGoogle Scholar
  124. 124.
    Miao H, Liu C, Bishop K, et al. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain. J Neurochem 1998; 70: 752–62PubMedCrossRefGoogle Scholar
  125. 125.
    Slotkin TA, Orband-Miller L, Queen KL, et al. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther 1987; 240: 602–11PubMedGoogle Scholar
  126. 126.
    Slotkin TA, Orband-Miller L, Queen KL. Development of [3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. J Pharmacol Exp Ther 1987; 242: 232–7PubMedGoogle Scholar
  127. 127.
    Navarro HA, Seidler FJ, Whitmore WL, et al. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther 1988; 244: 940–4PubMedGoogle Scholar
  128. 128.
    Fung YK, Lau YS. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol Biochem Behav 1989; 33: 1–6PubMedCrossRefGoogle Scholar
  129. 129.
    Navarro HA, Seidler FJ, Schwartz RD, et al. Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull 1989; 23: 187–92PubMedCrossRefGoogle Scholar
  130. 130.
    Ribary U, Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J Pharmacol Exp Ther 1989; 248: 786–92PubMedGoogle Scholar
  131. 131.
    Navarro HA, Seidler FJ, Eylers JP, et al. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther 1989; 251: 894–900PubMedGoogle Scholar
  132. 132.
    Slotkin TA, Lappi SE, Tayyeb MI, et al. Chronic prenatal nicotine exposure sensitizes rat brain to acute postnatal nicotine challenge as assessed with ornithine decarboxylase. Life Sci 1991; 49: 665–70PubMedCrossRefGoogle Scholar
  133. 133.
    Slotkin TA, McCook EC, Lappi SE, et al. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Brain Res Dev Brain Res 1992; 68: 233–9PubMedCrossRefGoogle Scholar
  134. 134.
    Seidler FJ, Levin ED, Lappi SE, et al. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Brain Res Dev Brain Res 1992; 69: 288–91PubMedCrossRefGoogle Scholar
  135. 135.
    Zahalka EA, Seidler FJ, Lappi SE, et al. Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding. Neurotoxicol Teratol 1992; 14: 375–82PubMedCrossRefGoogle Scholar
  136. 136.
    Zahalka EA, Seidler FJ, Yanai J, et al. Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins. Neurotoxicol Teratol 1993; 15: 107–15PubMedCrossRefGoogle Scholar
  137. 137.
    Slotkin TA, Lappi SE, Seidler FJ. Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res Bull 1993; 31: 319–28PubMedCrossRefGoogle Scholar
  138. 138.
    Richardson SA, Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol Biochem Behav 1994; 47: 331–7PubMedCrossRefGoogle Scholar
  139. 139.
    Slotkin TA, McCook EC, Seidler FJ. Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res 1997; 750: 180–8PubMedCrossRefGoogle Scholar
  140. 140.
    Muneoka K, Ogawa T, Kamei K, et al. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res 1997; 102: 117–26PubMedCrossRefGoogle Scholar
  141. 141.
    Shacka JJ, Robinson SE. Exposure to prenatal nicotine transiently increases neuronal nicotinic receptor subunit alpha7, alpha4 and beta2 messenger RNAs in the postnatal rat brain. Neuroscience 1998; 84: 1151–61PubMedCrossRefGoogle Scholar
  142. 142.
    Zbuzek VK, Chin CW. Prenatal nicotine exposure increased duration of nicotine-induced analgesia in adult rats. Psychopharmacology (Berl) 1994; 113: 534–8CrossRefGoogle Scholar
  143. 143.
    Jonsson G, Hallman H. Effects ofneonatal nicotine administration on the postnatal development of central noradrenaline neurons. Acta Physiol Scand 1980; 479Suppl.: 25–6Google Scholar
  144. 144.
    Sershen H, Reith ME, Banay-Schwartz M, et al. Effects of prenatal administration of nicotine on amino acid pools, protein metabolism, and nicotine binding in the brain. Neurochem Res 1982; 7: 1515–22PubMedCrossRefGoogle Scholar
  145. 145.
    Fung YK. Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats. J Pharm Pharmacol 1989; 41: 576–8PubMedCrossRefGoogle Scholar
  146. 146.
    King JA, Davila-Garcia M, Azmitia EC, et al. Differential effects ofprenatal and postnatal ACTH or nicotine exposure on 5-HT high affinity uptake in the neonatal rat brain. Int J Dev Neurosci 1991; 9: 281–6PubMedCrossRefGoogle Scholar
  147. 147.
    Joschko MA, Dreosti IE, Tulsi RS. The teratogenic effects of nicotine in vitro in rats: a light and electron microscope study. Neurotoxicol Teratol 1991; 13: 307–16PubMedCrossRefGoogle Scholar
  148. 148.
    Zhu J, Takita M, Konishi Y, et al. Chronic nicotine treatment delays the developmental increase in brain muscarinic receptors in rat neonate. Brain Res 1996; 732: 257–60PubMedCrossRefGoogle Scholar
  149. 149.
    Amankwah KS, Kaufmann RC, Weberg AD. Ultrastructural changes in neonatal sciatic nerve tissue: effects of passive maternal smoking. Gynecol Obstet Invest 1985; 20: 186–93PubMedCrossRefGoogle Scholar
  150. 150.
    Rosenthal RN, Slotkin TA. Development of nicotinic responses in the rat adrenal medulla and long-term effects of neonatal nicotine administration. Br J Pharmacol 1977; 60: 59–64PubMedCrossRefGoogle Scholar
  151. 151.
    Seidler FJ, Slotkin TA. Non-neurogenic adrenal catecholamine release in the neonatal rat: exocytosis or diffusion? Brain Res 1986; 393: 274–7PubMedGoogle Scholar
  152. 152.
    Frischer RE, King JA, Rose KJ, et al. Maturational changes in neonatal rat motor system with early postnatal administration of nicotine. Int J Dev Neurosci 1988; 6: 149–54PubMedCrossRefGoogle Scholar
  153. 153.
    Rose KJ, Strand FL. Accelerated neuromuscular development in the rat with prenatal exposure to nicotine. Int J Dev Neurosci 1990; 8: 565–73PubMedCrossRefGoogle Scholar
  154. 154.
    Britos SA, Keller EA, Orsingher OA. Prenatal nicotine exposure induces cardiac adrenergic subsensitivity in adult rats. Acta Physiol Pharmacol Ther Latinoam 1992; 42: 217–24PubMedGoogle Scholar
  155. 155.
    Slotkin TA, Navarro HA, McCook EC, et al. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci 1990; 47: 1561–7PubMedCrossRefGoogle Scholar
  156. 156.
    Navarro HA, Mills E, Seidler FJ, et al. Prenatal nicotine exposure impairs beta-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull 1990; 25: 233–7PubMedCrossRefGoogle Scholar
  157. 157.
    Grunfeld JA, Tiedemann GJ, Westerman RA. Maternal nicotine exposure enhances cutaneous axon reflexes in the neonatal rat. Neuroreport 1993; 4: 635–8PubMedCrossRefGoogle Scholar
  158. 158.
    Holgert H, Hokfelt T, Hertzberg T, et al. Functional and developmental studies ofthe peripheral arterial chemoreceptors in rat: effects of nicotine and possible relation to sudden infant death syndrome. Proc Natl Acad Sci USA 1995; 92: 7575–9PubMedCrossRefGoogle Scholar
  159. 159.
    Slotkin TA, Lappi SE, McCook EC, et al. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull 1995; 38: 69–75PubMedCrossRefGoogle Scholar
  160. 160.
    Bamford OS, Schuen JN, Carroll JL. Effect of nicotine exposure on postnatal ventilatory responses to hypoxia and hypercapnia. Respir Physiol 1996; 106: 1–11PubMedCrossRefGoogle Scholar
  161. 161.
    Schuen JN, Bamford OS, Carroll JL. The cardiorespiratory response to anoxia: normal development and the effect of nicotine. Respir Physiol 1997; 109: 231–9PubMedCrossRefGoogle Scholar
  162. 162.
    Slotkin TA, Saleh JL, McCook EC, et al. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology 1997; 55: 177–84PubMedCrossRefGoogle Scholar
  163. 163.
    McLean BK, Rubel A, Nikitovitch-Winer MB. The differential effects of exposure to tobacco smoke on the secretion of luteinizing hormone and prolactin in the proestrous rat. Endocrinology 1977; 100: 1566–70PubMedCrossRefGoogle Scholar
  164. 164.
    Meyer DC, Carr LA. The effects ofperinatal exposure to nicotine on plasma LH levels in prepubertal rats. Neurotoxicol Teratol 1987; 9: 95–8PubMedCrossRefGoogle Scholar
  165. 165.
    Poland RE, Lutchmansingh P, Au D, et al. Exposure to threshold doses of nicotine in utero: I. Neuroendocrine response to restraint stress in adult male offspring. Life Sci 1994; 55: 1567–75PubMedCrossRefGoogle Scholar
  166. 166.
    Poland RE, Lutchmansingh P, Au D, et al. Exposure to threshold doses of nicotine in utero: II. Neuroendocrine response to nicotine in adult male offspring [published erratum appears in Brain Res Dev Brain Res 1995 Mar 16; 85 (1): 149]. Brain Res Dev Brain Res 1994; 83: 278–84PubMedCrossRefGoogle Scholar
  167. 167.
    Poland RE, Lutchmansingh P, Au D, et al. Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring. Neurotoxicology 1996; 17: 351–8PubMedGoogle Scholar
  168. 168.
    von Ziegler NI, Schlumpf M, Lichtensteiger W. Prenatal nicotine exposure selectively affects perinatal forebrain aromatase activity and fetal adrenal function in male rats. Brain Res Dev Brain Res 1991; 62: 23–31CrossRefGoogle Scholar
  169. 169.
    Lichtensteiger W, Schlumpf M. Prenatal nicotine affects fetal testosterone and sexual dimorphism of saccharin preference. Pharmacol Biochem Behav 1985; 23: 439–44PubMedCrossRefGoogle Scholar
  170. 170.
    Bnait KS, Seller MJ. Ultrastructural changes in 9-day old mouse embryos following maternal tobacco smoke inhalation. Exp Toxicol Pathol 1995; 47: 453–61PubMedGoogle Scholar
  171. 171.
    Rajini P, Last JA, Pinkerton KE, et al. Decreased fetal weights in rats exposed to sidestream cigarette smoke. Fundam Appl Toxicol 1994; 22: 400–4PubMedCrossRefGoogle Scholar
  172. 172.
    Reckzeh G, Dontewill W, Leuschner F. Testing of cigarette smoke inhalation for teratogenicity in rats. Toxicology 1975; 4: 289–95PubMedCrossRefGoogle Scholar
  173. 173.
    Seller MJ, Bnait KS. Effects of tobacco smoke inhalation on the developing mouse embryo and fetus. Reprod Toxicol 1995; 9: 449–59PubMedCrossRefGoogle Scholar
  174. 174.
    Paulson R, Shanfeld J, Sachs L, et al. Effect of smokeless tobacco on the development of the CD-1 mouse fetus. Teratog Carcinog Mutagen 1988; 8: 81–93PubMedCrossRefGoogle Scholar
  175. 175.
    Paulson R, Shanfeld J, Sachs L, et al. Effect of smokeless tobacco on the development of the CD-1 mouse fetus. Teratology 1989; 40: 483–94PubMedCrossRefGoogle Scholar
  176. 176.
    Paulson RB, Shanfeld J, Prause L, et al. Pre- and post-conceptional tobacco effects on the CD-1 mouse fetus. J Craniofac Genet Dev Biol 1991; 11: 48–58PubMedGoogle Scholar
  177. 177.
    Paulson RB, Shanfeld J, Mullet D, et al. Prenatal smokeless tobacco effects on the rat fetus. J Craniofac Genet Dev Biol 1994; 14: 16–25PubMedGoogle Scholar
  178. 178.
    Leblebicioglu-Bekcioglu B, Paulson RB, Paulson JO, et al. Effects of caffeine and nicotine administration on growth and ossification of the ICR mouse fetus. J Craniofac Genet Dev Biol 1995; 15: 146–56PubMedGoogle Scholar
  179. 179.
    Woo ND, Persaud TV. Rat embryogenesis following exposure to alcohol and nicotine. Acta Anat (Basel) 1988; 131: 122–6CrossRefGoogle Scholar
  180. 180.
    Nash JE, Persaud TV. Influence of nicotine and caffeine on skeletal development in the rat. Anat Anz 1989; 168: 109–26PubMedGoogle Scholar
  181. 181.
    Daeninck PJ, Messiha N, Persaud TV. Intrauterine development in the rat following continuous exposure to nicotine from gestational day 6 through 12. Anat Anz 1991; 172: 257–61PubMedGoogle Scholar
  182. 182.
    Saad AY, Gartner LP, Hiatt JL. Teratogenic effects of nicotine on palate formation in mice. Biol Struct Morphog 1990; 3: 31–5PubMedGoogle Scholar
  183. 183.
    Saad AY. Postnatal effects of nicotine on incisor development of albino mouse. J Oral Pathol Med 1990; 19: 426–9PubMedCrossRefGoogle Scholar
  184. 184.
    Saad AY. Postnatal effects of nicotine on first molar development in the CD-1mouse. Acta Anat (Basel) 1991; 140: 269–72CrossRefGoogle Scholar
  185. 185.
    Saad AY, Gartner LP, Hiatt JL. Teratogenic effects of nicotine on first molar odontogenesis in the mouse. Acta Morphol Hung 1991; 39: 87–96PubMedGoogle Scholar
  186. 186.
    Gartner LP, Saad AY, Hiatt JL. Effects of nicotine on murine incisor development. J Biol Buccale 1990; 18: 83–8PubMedGoogle Scholar
  187. 187.
    Gartner LP, Saad AY, Hiatt JL. Effects of nicotine on tongue development in the CD-1 mouse. Eur J Morphol 1997; 35: 337–43PubMedCrossRefGoogle Scholar
  188. 188.
    Balansky RM, Blagoeva PM. Tobacco smoke-induced clastogenicity in mouse fetuses and in newborn mice. Mutat Res 1989; 223: 1–6PubMedCrossRefGoogle Scholar
  189. 189.
    Magers T, Talbot P, DiCarlantonio G, et al. Cigarette smoke inhalation affects the reproductive system of female hamsters. Reprod Toxicol 1995; 9: 513–25PubMedCrossRefGoogle Scholar
  190. 190.
    Knoll M, Talbot P. Cigarette smoke inhibits oocyte cumulus complex pick-up by the oviduct in vitro independent of ciliary beat frequency. Reprod Toxicol 1998; 12: 57–68PubMedCrossRefGoogle Scholar
  191. 191.
    McArdle HJ, Tysoe J. Effect of nicotine on transferrin binding and iron uptake by cultured rat placenta. J Cell Physiol 1988; 134: 509–13PubMedCrossRefGoogle Scholar
  192. 192.
    Baldwin KV, Racowsky C. Nicotine and cotinine effects on development of two-cell mouse embryos in vitro. Reprod Toxicol 1987; 1: 173–8PubMedCrossRefGoogle Scholar
  193. 193.
    Knoll M, Shaoulian R, Magers T, et al. Ciliary beat frequency of hamster oviducts is decreased in vitro by exposure to solutions of mainstream and sidestream cigarette smoke. Biol Reprod 1995; 53: 29–37PubMedCrossRefGoogle Scholar
  194. 194.
    Murrin LC, Ferrer JR, Zeng WY, et al. Nicotine administration to rats: methodological considerations. Life Sci 1987; 40: 1699–708PubMedCrossRefGoogle Scholar
  195. 195.
    Schoendorf KC, Kiely JL. Relationship of sudden infant death syndrome to maternal smoking during and after pregnancy. Pediatrics 1992; 90: 905–8PubMedGoogle Scholar
  196. 196.
    Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax 1997; 52: 1003–9PubMedCrossRefGoogle Scholar
  197. 197.
    Penney DG. Effects of carbon monoxide exposure on developing animals and humans. In: Penney DG, editor. Carbon Monoxide. Boca Raton (FL): CRC Press, 1996: 109–44Google Scholar
  198. 198.
    Nageotte MP, Towers CV, Asrat T, et al. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol 1994; 170: 1672–6PubMedGoogle Scholar
  199. 199.
    Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 1996; 174: 812–7PubMedCrossRefGoogle Scholar
  200. 200.
    Smith CV, Phelan JP, Paul RH. A prospective analysis of the influence of gestational age on the baseline fetal heart rate and reactivity in a low risk population. Am J Obstet Gynecol 1985; 153: 780PubMedGoogle Scholar
  201. 201.
    Druzin NL, Fox A, Kogut E, et al. The relationship of the non-stress test to gestational age. Am J Obstet Gynecol 1985; 153: 386PubMedGoogle Scholar
  202. 202.
    Sindberg Eriksen P, Marsal K. Acute effects of maternal smoking on fetal blood flow. Acta Obstet Gynecol Scand 1984; 63: 391–7PubMedCrossRefGoogle Scholar
  203. 203.
    Spira A, Spira N, Goujard J, et al. Smoking during pregnancy and placental weight: a multivariate analysis on 3759 cases. J Perinat Med 1975; 3: 237–41PubMedCrossRefGoogle Scholar
  204. 204.
    Christianson RE. Gross differences observed in the placentas of smokers and nonsmokers. Am J Epidemiol 1979; 110: 178–87PubMedGoogle Scholar
  205. 205.
    Picone TA, Allen LH, Olsen PN, et al. Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress, and weight gain on placentas, and on neonatal physical and behavioral characteristics. Am J Clin Nutr 1982; 36: 1214–24PubMedGoogle Scholar
  206. 206.
    Sanyal MK, Li YL, Belanger K. Metabolism of polynuclear aromatic hydrocarbon in human term placenta influenced by cigarette smoke exposure. Reprod Toxicol 1994; 8: 411–8PubMedCrossRefGoogle Scholar
  207. 207.
    Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother: a quantitative and ultrastructural study. Pathol Res Pract 1994; 190: 656–67PubMedCrossRefGoogle Scholar
  208. 208.
    Howe DT, Wheeler T, Osmond C. The influence of maternal haemoglobin and ferritin on mid-pregnancy placental volume. Br J Obstet Gynaecol 1995; 102: 213–9PubMedCrossRefGoogle Scholar
  209. 209.
    Ellard GA, Johnstone FD, Prescott RJ, et al. Smoking during pregnancy: the dose dependence ofbirthweight deficits. Br J Obstet Gynaecol 1996; 103: 806–13PubMedCrossRefGoogle Scholar
  210. 210.
    McFadyen IR, Price AB, Geirsson RT. The relation of birthweight to histological appearances in vessels ofthe placental bed. Br J Obstet Gynaecol 1986; 93: 476–81PubMedGoogle Scholar
  211. 211.
    Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96: 907–15PubMedCrossRefGoogle Scholar
  212. 212.
    Arnholdt H, Meisel F, Fandrey K, et al. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 365–72PubMedCrossRefGoogle Scholar
  213. 213.
    Gupta I, Hillier VF, Edwards JM. Multiple vascular profiles in the umbilical cord; an indication of maternal smoking habits and intrauterine distress. Placenta 1993; 14: 117–23PubMedCrossRefGoogle Scholar
  214. 214.
    Genbacev O, Bass KE, Joslin RJ, et al. Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod Toxicol 1995; 9: 245–55PubMedCrossRefGoogle Scholar
  215. 215.
    Klesges LM, Murray DM, Brown JE, et al. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am J Epidemiol 1998; 147: 127–35PubMedCrossRefGoogle Scholar
  216. 216.
    Lee JN, Grudzinskas JG, Chard T. Effect of smoking on maternal blood SP1 levels in late pregnancy. Obstet Gynecol 1981; 57: 220–3PubMedGoogle Scholar
  217. 217.
    Suarez A, Rico F, Clavero-Nunez JA, et al. Amniotic fluid catecholamine metabolites in maternal smoking. Gynecol Obstet Invest 1990; 30: 143–6PubMedCrossRefGoogle Scholar
  218. 218.
    Andreucci D, Teodoro WR, Mariani C. Very high collagen increase in placentae of smoking mothers. Gynecol Obstet Invest 1992; 34: 88–91PubMedCrossRefGoogle Scholar
  219. 219.
    Shimizu T, Dudley DK, Borodchack P, et al. Effect of smoking on fibronectin production by human amnion and placenta. Gynecol Obstet Invest 1992; 34: 142–5PubMedCrossRefGoogle Scholar
  220. 220.
    Belaaouaj A, Shipley JM, Kobayashi DK, et al. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995; 270: 14568–75PubMedCrossRefGoogle Scholar
  221. 221.
    Ulm MR, Plockinger B, Pirich C, et al. Umbilical arteries of babies born to cigarette smokers generate less prostacyclin and contain less arginine and citrulline compared with those of babies born to control subjects. Am J Obstet Gynecol 1995; 172: 1485–7PubMedCrossRefGoogle Scholar
  222. 222.
    Sooranna SR, Morris NH, Steer PJ. Placental nitric oxide metabolism. Reprod Fertil Dev 1995; 7: 1525–31PubMedCrossRefGoogle Scholar
  223. 223.
    Schenker S, Johnson RF, Hays SE, et al. Effects of nicotine and nicotine/ethanol on human placental amino acids transfer. Alcohol 1989; 6: 289–96PubMedCrossRefGoogle Scholar
  224. 224.
    Sastry BV. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod Fertil Dev 1991; 3: 355–72PubMedCrossRefGoogle Scholar
  225. 225.
    Anand RJ, Kanwar U, Sanyal SN. Transport of glycine in the brush border and basal cell membrane vesicles of the human term placenta. Biochem Mol Biol Int 1996; 38: 21–30PubMedGoogle Scholar
  226. 226.
    Gabriel R, Alsat E, Evain-Brion D. Alteration of epidermal growth factor receptor in placental membranes of smokers: relationship with intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1238–43PubMedGoogle Scholar
  227. 227.
    Guyda HJ. Metabolic effects of growth factors and polycyclic aromatic hydrocarbons on cultured human placental cells of early and late gestation. J Clin Endocrinol Metab 1991; 72: 718–23PubMedCrossRefGoogle Scholar
  228. 228.
    Zhang L, Connor EE, Chegini N, et al. Modulation by benzo[a]pyrene of epidermal growth factor receptors, cell proliferation, and secretion of human chorionic gonadotropin in human placental cell lines. Biochem Pharmacol 1995; 50: 1171–80PubMedCrossRefGoogle Scholar
  229. 229.
    Evans P, Wheeler T, Anthony F, et al. Maternal serum vascular endothelial growth factor during early pregnancy. Clin Sci (Colch) 1997; 92: 567–71Google Scholar
  230. 230.
    Boyce A, Schwartz D, Hubert C, et al. Smoking, human placental lactogen and birth weight. Br J Obstet Gynaecol 1975; 82: 964–7PubMedCrossRefGoogle Scholar
  231. 231.
    Spellacy WN, Buhi WC, Birk A. The effect of smoking on serum human placental lactogen levels. Am J Obstet Gynecol 1977; 127: 232–4PubMedGoogle Scholar
  232. 232.
    Andersen AN, Ronn B, Tjonneland A, et al. Low maternal but normal fetal prolactin levels in cigarette smoking pregnant women. Acta Obstet Gynecol Scand 1984; 63: 237–9PubMedCrossRefGoogle Scholar
  233. 233.
    Weiss T, Eckert A. Cotinine levels in follicular fluid and serum of IVF patients: effect on granulosa-luteal cell function in vitro. Hum Reprod 1989; 4: 482–5PubMedGoogle Scholar
  234. 234.
    Barbieri RL, Friedman AJ, Osathanondh R. Cotinine and nicotine inhibit human fetal adrenal 11 beta-hydroxylase. J Clin Endocrinol Metab 1989; 69: 1221–4PubMedCrossRefGoogle Scholar
  235. 235.
    Bremme K, Lagerstrom M, Andersson O, et al. Influences of maternal smoking and fetal sex on maternal serum oestriol, prolactin, hCG, and hPI levels. Arch Gynecol Obstet 1990; 247: 95–103PubMedCrossRefGoogle Scholar
  236. 236.
    Gocze PM, Porpaczy Z, Freeman DA. Effect of alkaloids in cigarette smoke on human granulosa cell progesterone synthesis and cell viability. Gynecol Endocrinol 1996; 10: 223–8PubMedCrossRefGoogle Scholar
  237. 237.
    Benediktsson R, Magnusdottir EM, Seckl JR. Lack of effect of nicotine or ethanol on the activity of 11beta-hydroxysteroid dehydrogenase type 2. J Steroid Biochem Mol Biol 1997; 63: 303–7PubMedCrossRefGoogle Scholar
  238. 238.
    Mochizuki M, Maruo T, Masuko K, et al. Effects of smoking on fetoplacental-maternal system during pregnancy. Am J Obstet Gynecol 1984; 149: 413–20PubMedGoogle Scholar
  239. 239.
    Pasanen M. Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biol Res Pregnancy Perinatol 1985; 6: 94–9PubMedGoogle Scholar
  240. 240.
    Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 1986; 77: 1727–33PubMedCrossRefGoogle Scholar
  241. 241.
    Petridou E, Panagiotopoulou K, Katsouyanni K, et al. Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1990; 1: 247–50PubMedCrossRefGoogle Scholar
  242. 242.
    Kitawaki J, Inoue S, Tamura T, et al. Cigarette smoking during pregnancy lowers aromatase cytochrome P-450 in the human placenta. J Steroid Biochem Mol Biol 1993; 45: 485–91PubMedCrossRefGoogle Scholar
  243. 243.
    Osawa Y, Tochigi B, Tochigi M, et al. Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants. J Enzyme Inhib 1990; 4: 187–200PubMedCrossRefGoogle Scholar
  244. 244.
    Kadohama N, Shintani K, Osawa Y. Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase. Cancer Lett 1993; 75: 175–82PubMedCrossRefGoogle Scholar
  245. 245.
    Stoel I, v.d. Giessen WJ, Zwolsman E, et al. Effect of nicotine on production of prostacyclin in human umbilical artery. Br Heart J 1982; 48: 493–6PubMedCrossRefGoogle Scholar
  246. 246.
    Dadak C, Kefalides A, Sinzinger H, et al. Reduced umbilical artery prostacyclin formation in complicated pregnancies. Am J Obstet Gynecol 1982; 144: 792–5PubMedGoogle Scholar
  247. 247.
    Dadak C, Deutinger J, Reinthaller A, et al. Prostaglandin metabolism in umbilical vessels of smoking and non-smoking mothers. Arch Gynecol 1987; 240: 9–12PubMedCrossRefGoogle Scholar
  248. 248.
    Busacca M, Balconi G, Pietra A, et al. Maternal smoking and prostacyclin production by cultured endothelial cells from umbilical arteries. Am J Obstet Gynecol 1984; 148: 1127–30PubMedGoogle Scholar
  249. 249.
    Busacca M, Breviario F, Agarossi A, et al. Effect of cigarette smoking on plasmatic regulation of vascular prostacyclin in pregnancy and puerperium. Obstet Gynecol 1986; 68: 816–9PubMedGoogle Scholar
  250. 250.
    Ylikorkala O, Viinikka L, Lehtovirta P. Effect of nicotine on fetal prostacyclin and thromboxane in humans. Obstet Gynecol 1985; 66: 102–5PubMedGoogle Scholar
  251. 251.
    Ahlsten G, Ewald U, Kindahl H, et al. Aggregation of and thromboxane B2 synthesis in platelets from newborn infants of smoking and non-smoking mothers. Prostaglandins Leukot Med 1985; 19: 167–76PubMedCrossRefGoogle Scholar
  252. 252.
    Ahlsten G, Ewald U, Tuvemo T. Maternal smoking reduces prostacyclin formation in human umbilical arteries. A study on strictly selected pregnancies. Acta Obstet Gynecol Scand 1986; 65: 645–9PubMedCrossRefGoogle Scholar
  253. 253.
    Ahlsten G, Ewald U, Tuvemo T. Prostacyclin-like activity in umbilical arteries is dose-dependently reduced by maternal smoking and related to nicotine levels. Biol Neonate 1990; 58: 271–8PubMedCrossRefGoogle Scholar
  254. 254.
    Ylikorkala O, Halmesmaki E, Viinikka L. Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. Obstet Gynecol 1988; 71: 61–6PubMedGoogle Scholar
  255. 255.
    Viinikka L, Kaapa P, Ylikorkala O. Maternal smoking and neonatal prostacyclin excretion. Dev Pharmacol Ther 1988; 11: 88–91PubMedGoogle Scholar
  256. 256.
    Narahara H, Johnston JM. Smoking and preterm labor: effect of a cigarette smoke extract on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol 1993; 169: 1321–6PubMedGoogle Scholar
  257. 257.
    Schellenberg JC, North RA, Taylor R, et al. Secretory component of immunoglobulin A in maternal serum and the prediction of preterm delivery. Am J Obstet Gynecol 1998; 178: 535–9PubMedCrossRefGoogle Scholar
  258. 258.
    D’Souza SW, Black PM, Williams N, et al. Effect of smoking during pregnancy upon the haematological values of cord blood. Br J Obstet Gynaecol 1978; 85: 495–9PubMedCrossRefGoogle Scholar
  259. 259.
    Meberg A, Haga P, Sande H, et al. Smoking during pregnancy-hematological observations in the newborn. Acta Paediatr Scand 1979; 68: 731–4PubMedCrossRefGoogle Scholar
  260. 260.
    Boomer AL, Christensen BL. Antepartum hematocrit, maternal smoking and birth weight. J Reprod Med 1982; 27: 385–8PubMedGoogle Scholar
  261. 261.
    Bureau MA, Shapcott D, Berthiaume Y, et al. Maternal cigarette smoking and fetal oxygen transport: a study of P50, 2,3-diphosphoglycerate, total hemoglobin, hematocrit, and type F hemoglobin in fetal blood. Pediatrics 1983; 72: 22–6PubMedGoogle Scholar
  262. 262.
    Leuschen MP, Davis RB, Boyd D, et al. Comparative evaluation of antepartum and postpartum platelet function in smokers and nonsmokers. Am J Obstet Gynecol 1986; 155: 1276–80PubMedGoogle Scholar
  263. 263.
    Nordenvall M, Sandstedt B. Placental lesions and maternal hemoglobin levels. A comparative investigation. Acta Obstet Gynecol Scand 1990; 69: 127–33PubMedCrossRefGoogle Scholar
  264. 264.
    Wheeler T, Sollero C, Alderman S, et al. Relation between maternal haemoglobin and placental hormone concentrations in early pregnancy. Lancet 1994; 343: 511–3PubMedCrossRefGoogle Scholar
  265. 265.
    Dalamaga AL, Agroyannis B, Vitoratos N, et al. Effect of smoking on ceruloplasmin and its ferroxidase activity in pregnant women. Gynecol Obstet Invest 1996; 42: 13–5PubMedCrossRefGoogle Scholar
  266. 266.
    Bili H, Mamopoulos M, Tsantali C, et al. Elevated umbilical erythropoietin levels during labor in newborns of smoking mothers. Am J Perinatol 1996; 13: 85–7PubMedCrossRefGoogle Scholar
  267. 267.
    Zaren B, Lindmark G, Bergsjo P. Hemoconcentration in smoking mothers is associated with impaired fetal growth. Acta Obstet Gynecol Scand 1997; 76: 933–41PubMedCrossRefGoogle Scholar
  268. 268.
    Jazayeri A, Tsibris JC, Spellacy WN. Umbilical cord plasma erythropoietin levels in pregnancies complicated by maternal smoking. Am J Obstet Gynecol 1998; 178: 433–5PubMedCrossRefGoogle Scholar
  269. 269.
    French JI, McGregor JA. The pathobiology of premature rupture of membranes. Semin Perinatol 1996; 20: 344–68PubMedCrossRefGoogle Scholar
  270. 270.
    Bullion K, Ohnishi S, Osawa Y. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives. Endocr Res 1991; 17: 409–19PubMedCrossRefGoogle Scholar
  271. 271.
    Meyer MB, Tonascia JA. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977; 128: 494–502PubMedGoogle Scholar
  272. 272.
    Shiono PH, Klebanoff MA, Rhoads GG. Smoking and drinking during pregnancy. Their effects on preterm birth. JAMA 1986; 255: 82–4PubMedCrossRefGoogle Scholar
  273. 273.
    Hadley CB, Main DM, Gabbe SG. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990; 7: 374–9PubMedCrossRefGoogle Scholar
  274. 274.
    Gadek JE, Fells GA, Crystal RG. Cigarette smoke induced functional antiprotease deficiency in the lower respiratory tract of humans. Science 1979; 206: 1315PubMedCrossRefGoogle Scholar
  275. 275.
    Barton SE, Maddox PH, Jenkins D, et al. Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change? Lancet 1988; II: 652–4CrossRefGoogle Scholar
  276. 276.
    Burns DN, Landesman S, Muenz LR, et al. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immunol Def Syndrome 1994; 7: 718–26Google Scholar
  277. 277.
    Fisher GL, McNeill KL, Finch GL, et al. Functional evaluation of lung macrophages from cigarette smokers and nonsmokers. J Reticuloendothel Soc 1982; 32: 311–21PubMedGoogle Scholar
  278. 278.
    Cunningham FG, MacDonald PC, Gant NF, et al. The placenta and fetal membranes. In: Cunningham FG, editor. Williams obstetrics, 20th ed. Stamford, (CT): Appleton & Lange, 1997: 95–124Google Scholar
  279. 279.
    Phillips CL, Tajima S, Pinnell SR. Ascorbic acid and transforming growth factor-b-1 increase collagen biosynthesis via different mechanisms: Coordinate regulation of pro-alpha-1(I) and pro-alpha 1(III) collagens. Arch Biochem Biophys 1982; 295: 397–403CrossRefGoogle Scholar
  280. 280.
    Wideman GL, Baird GH, Bolding OT. Ascorbic acid deficiency and premature rupture of fetal membranes. Am J Obstet Gynecol 1964; 88: 592–5PubMedGoogle Scholar
  281. 281.
    Barrett B, Gunter E, Jenkins J, et al. Ascorbic acid concentration in amniotic fluid in late pregnancy. Biol Neonate 1991; 60: 333–5PubMedCrossRefGoogle Scholar
  282. 282.
    Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health 1989; 79: 158–62PubMedCrossRefGoogle Scholar
  283. 283.
    Anderson R. Effects of ascorbate on leukocytes. Part II. Effects of ascorbic acid and calcium and sodium ascorbate on neutrophil phagocytosis and post-phagocytic metabolic activity. S Afr Med J 1979; 56: 401–4PubMedGoogle Scholar
  284. 284.
    Casanueva E, Magana L, Pfeffer F, et al. Incidence of premature rupture of membranes in pregnant women with low leukocyte levels of vitamin C. Eur J Clin Nutr 1991; 45: 401–5PubMedGoogle Scholar
  285. 285.
    Casanueva E, Polo E, Tejero E, et al. Premature rupture of amniotic membranes as functional assessment of vitamin C status during pregnancy. Ann NY Acad Sci 1993; 678: 369–70PubMedCrossRefGoogle Scholar
  286. 286.
    Kuhnert BR, Kuhnert PM, Debanne S, et al. The relationship between cadmium, zinc, and birth weight in pregnant women who smoke. Am J Obstet Gynecol 1987; 157: 1247–51PubMedGoogle Scholar
  287. 287.
    Kuhnert PM, Kuhnert BR, Bottoms SF, et al. Cadmium levels in maternal blood, fetal cord blood, and placental tissues of pregnant women who smoke. Am J Obstet Gynecol 1982; 142: 1021–5PubMedGoogle Scholar
  288. 288.
    Chatterjee MS, Abdel-Rahman M, Bhandal A, et al. Amniotic fluid cadmium and thiocyanate in pregnant women who smoke. J Reprod Med 1988; 33: 417–20PubMedGoogle Scholar
  289. 289.
    Lagerkvist BJ, Nordberg GF, Soderberg HA, et al. Placental transfer of cadmium. IARC Sci Publ 1992; 287–91Google Scholar
  290. 290.
    Lagerkvist BJ, Soderberg HA, Nordberg GF, et al. Biological monitoring of arsenic, lead and cadmium in occupationally and environmentally exposed pregnant women. Scand J Work Environ Health 1993; 19Suppl. 1: 50–3PubMedGoogle Scholar
  291. 291.
    Kuhnert PM, Kuhnert BR, Erhard P, et al. The effect of smoking on placental and fetal zinc status. Am J Obstet Gynecol 1987; 157: 1241–6PubMedGoogle Scholar
  292. 292.
    Kuhnert BR, Kuhnert PM, Zarlingo TJ. Associations between placental cadmium and zinc and age and parity in pregnant women who smoke. Obstet Gynecol 1988; 71: 67–70PubMedGoogle Scholar
  293. 293.
    Kuhnert BR, Kuhnert PM, Groh-Wargo SL, et al. Smoking alters the relationship between maternal zinc intake and biochemical indices of fetal zinc status. Am J Clin Nutr 1992; 55: 981–4PubMedGoogle Scholar
  294. 294.
    Kuhnert BR, Kuhnert PM, Lazebnik N, et al. The relationship between placental cadmium, zinc, and copper. J Am Coll Nutr 1993; 12: 31–5PubMedGoogle Scholar
  295. 295.
    King LA, MacDonald PC, Casey ML. Regulation of metallothionein expression in human amnion epithelial and mesenchymal cells. Am J Obstet Gynecol 1997; 177: 1496–501PubMedCrossRefGoogle Scholar
  296. 296.
    Chambers RC, McAnulty RJ, Shock A, et al. Cadmium selectively inhibits fibroblast procollagen production and proliferation. Am J Physiol 1994; 267(3 Pt 1): L300–8PubMedGoogle Scholar
  297. 297.
    Cunningham FG, MacDonald PC, Gant NF, et al. Preterm birth. In: Cunningham FG, editor. Williams obstetrics, 20th ed. Stamford (CT): Appleton & Lange, 1997: 797–826Google Scholar
  298. 298.
    Leeson SC, Maresh MJA, Martindale EA, et al. Detection of fetal fibronectin as a predictor ofpreterm delivery in high risk symptomatic pregnancies. Br J Obstet Gynaecol 1996; 103: 48–53PubMedCrossRefGoogle Scholar
  299. 299.
    Carnevali S, Nakamura Y, Mio T, et al. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol 1998; 274(4 Pt 1): L591–8PubMedGoogle Scholar
  300. 300.
    Sastry BVR, Mouton S, Janson VE, et al. Tobacco smoking by pregnant women. Disturbances in metabolism of branched chain amino acids and fetal growth. Ann NY Acad Sci 1989; 678: 361–3CrossRefGoogle Scholar
  301. 301.
    Keelan JA, Coleman M, Mitchell MD. The molecular mechanisms of term and preterm labor: Recent progress and clinical implications. Clin Obstet Gynecol 1997; 40: 460–78PubMedCrossRefGoogle Scholar
  302. 302.
    Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149–55PubMedCrossRefGoogle Scholar
  303. 303.
    Koren G, Sharav T, Pastuszak A, et al. A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy. Reprod Toxicol 1991; 5: 397–403PubMedCrossRefGoogle Scholar
  304. 304.
    Norman CA, Halton DM. Is carbon monoxide a workplace teratogen? A review and evaluation of the literature. Ann Occup Hyg 1990; 34: 335–47PubMedCrossRefGoogle Scholar
  305. 305.
    Sauter D. Hematologic principles. In: Goldfrank LR, Weisman RS, Flomenbaum NE, et al, editors. Toxicologic emergencies. Norwalk (CT): Appleton & Lange, 1994: 345–64Google Scholar
  306. 306.
    Bureau MA, Monette J, Shapcott D, et al. Carboxyhemoglobin concentration in fetal cord blood and in blood ofmothers who smoked during labor. Pediatrics 1982; 69: 371–3PubMedGoogle Scholar
  307. 307.
    Longo LD. The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am J Obstet Gynecol 1977; 129: 69–103PubMedGoogle Scholar
  308. 308.
    Cole PV, Hawkins LH, Roberts D. Smoking during pregnancy and its effects on the fetus. J Obstet Gynaecol Br Commonw 1972; 79: 782–7PubMedCrossRefGoogle Scholar
  309. 309.
    Buchan PC. Cigarette smoking in pregnancy and fetal hyperviscosity. Br Med J (Clin Res Ed) 1983; 286: 1315CrossRefGoogle Scholar
  310. 310.
    Knottnerus JA, Delgado LR, Knipschild PG, et al. Haematologic parameters and pregnancy outcome. A prospective cohort study in the third trimester. J Clin Epidemiol 1990; 43: 461–6PubMedCrossRefGoogle Scholar
  311. 311.
    Longo LD. Carbon monoxide: effects on oxygenation of the fetus in utero. Science 1976; 194: 523–5PubMedCrossRefGoogle Scholar
  312. 312.
    Delivoria-Papadapoulos M, McGowan JE. Oxygen transport and delivery. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia (PA): W.B. Saunders Company, 1998: 1105–17Google Scholar
  313. 313.
    Hsia CCW. Respiratory function of hemoglobin. N Engl J Med 1998; 338: 239–47PubMedCrossRefGoogle Scholar
  314. 314.
    Garvey DJ, Longo LD. Chronic low level maternal carbon monoxide exposure and fetal growth and development. Biol Reprod 1978; 19: 8–14PubMedCrossRefGoogle Scholar
  315. 315.
    Lynch A-M, Bruce NW. Placental growth in rats exposed to carbon monoxide at selected stages of pregnancy. Biol Neonate 1989; 56: 151–7PubMedCrossRefGoogle Scholar
  316. 316.
    Storm JE, Fechter LD. Alteration in the postnatal ontogeny of cerebellar norepinephrine content following chronic prenatal carbon monoxide. J Neurochem 1985; 45: 965–9PubMedCrossRefGoogle Scholar
  317. 317.
    Storm JE, Fechter LD. Prenatal carbon monoxide exposure differentially affects postnatal weight and monoamine concentration of rat brain regions. Toxicol Appl Pharmacol 1985; 81: 139PubMedCrossRefGoogle Scholar
  318. 318.
    Storm JE, Valdes JJ, Fechter LD. Postnatal alterations in cerebellar GABA content, GABA up take and morphology following exposure to carbon monoxide early in development. Dev Neurosci 1986; 8: 251–61PubMedCrossRefGoogle Scholar
  319. 319.
    Fechter LD. Neurotoxicity of prenatal carbon monoxide exposure. Baltimore (MD): Health Effects Institute, 1987. Report no.: 12Google Scholar
  320. 320.
    Packianathan S, Cain CD, Stagg RB, et al. Ornithine decarboxylase activity in fetal and newborn rat brain: responses to hypoxia and carbon monoxide hypoxia. Dev Brain Res 1993; 76: 131–40CrossRefGoogle Scholar
  321. 321.
    Carratu MR, Renna G, Giustino A, et al. Changes in peripheral nervous system activity produced in rats by prenatal exposure to carbon monoxide. Arch Toxicol 1993; 67: 297–301PubMedCrossRefGoogle Scholar
  322. 322.
    Carratu MR, Cagiano R, DeSalvia MA, et al. Wallerian degeneration in rat sciatic nerve comparative evaluation between prenatal and postnatal exposure to carbon monoxide. Soc Neurosci 1993; 19: 834Google Scholar
  323. 323.
    Abbatiello ER, Mohrman K. Effects on the offspring of chronic low exposure carbon monoxide during mice pregnancy. Clin Toxicol 1979; 14: 401–6PubMedCrossRefGoogle Scholar
  324. 324.
    Singh J. Early behavioral alterations in mice following prenatal carbon monoxide exposure. Neurotoxicology 1986; 7: 475–81PubMedGoogle Scholar
  325. 325.
    Fechter LD, Annau Z. Toxicity of mild prenatal carbon monoxide exposure. Science 1977; 197: 680PubMedCrossRefGoogle Scholar
  326. 326.
    Fechter LD, Annau Z. Effects ofprenatal carbon monoxide exposure on neonatal rats. Adverse Effects Environ Chem Psychotropic Drugs 1976; 2: 219Google Scholar
  327. 327.
    Fechter LD, Annau Z. Prenatal carbon monoxide exposure alters behavioral development. Neurobehav Toxicol 1980; 2: 7PubMedGoogle Scholar
  328. 328.
    Mactutus CF, Fechter LD. Prenatal exposure to carbon monoxide: Learning and memory deficits. Science 1984; 223: 409PubMedCrossRefGoogle Scholar
  329. 329.
    Mactutus CF, Fechter LD. Moderate prenatal carbon monoxide exposure produces persistent, and apparently permanent, memory deficits in rats. Teratology 1985; 31: 1PubMedCrossRefGoogle Scholar
  330. 330.
    Penney DG, Baylerian MS, Thill JE, et al. The cardiac response of the fetal rat to carbon monoxide exposure. Am J Physiol 1983; 244: H289PubMedGoogle Scholar
  331. 331.
    Clubb Jr FJ, Penney DG, Bishop SP. Cardiomegaly in neonatal rats exposed to 500 ppm carbon monoxide. J Mol Cell Cardiol 1986; 21: 945CrossRefGoogle Scholar
  332. 332.
    Clubb FJ, Penney DG, Baylerian MS, et al. Cardiomegaly due to myocyte hyperplasia in perinatal rats exposed to 200 ppm carbon monoxide. J Mol Cell Cardiol 1986; 18: 477PubMedCrossRefGoogle Scholar
  333. 333.
    Penney DG, Caldwell-Ayre TM, Gargulinski RB, et al. Effect of littersize (i.e., nutrition) on carbon monoxide-induced persistent heart changes. Growth 1987; 51: 321PubMedGoogle Scholar
  334. 334.
    Piantadosi CA. Toxicity of carbon monoxide: Hemoglobin vs. histotoxic mechanisms. In: Penney DG, editor. Carbon monoxide. Boca Raton (FL): CRC Press, 1996: 163–86Google Scholar
  335. 335.
    Prabhakar NR, Fitzgerald RS. Carbon monoxide: from tool to neurotransmitter. In: Penney DG, editor. Carbon monoxide. Boca Raton (FL): CRC Press, 1996: 145–62Google Scholar
  336. 336.
    Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide, a putative neural messenger. Science 1993; 259: 381–4PubMedCrossRefGoogle Scholar
  337. 337.
    Prabhakar NR, Dinerman JL, Agani FA, et al. Carbon monoxide: a role in carotid body chemoreception. Proc Natl Acad Sci 1995; 92: 1994PubMedCrossRefGoogle Scholar
  338. 338.
    Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. Arch Int Med 1991; 151: 749–52CrossRefGoogle Scholar
  339. 339.
    Benowitz NL, Jacob PJ, Denaro C, et al. Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Therapy 1991; 49: 270–7CrossRefGoogle Scholar
  340. 340.
    Dahlstrom A, Lundell B, Curvall M, et al. Nicotine and cotinine concentrations in the nursing mother and her infant. Acta Paediatr Scand 1990; 79: 142–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  1. 1.Departments of Pediatrics and MedicineUniversity of California, Division of Clinical Pharmacology and Experimental Therapeutics, San Francisco General Hospital Medical CenterSan FranciscoUSA
  2. 2.Departments Medicine, Psychiatry, and Biopharmaceutical SciencesUniversity of California, Division of Clinical Pharmacology and Experimental Therapeutics, San Francisco General Hospital Medical CenterSan FranciscoUSA

Personalised recommendations